Bode BW, Testa MA, Magwire M, et al
However, substantial weight loss achieved through any meansincluding pharmacotherapymay indirectly influence cortisol metabolism and HPA axis function
For the prospectively planned substudy published in Hypertension , de Lemos and colleagues analyzed data from 600 of the SURMOUNT-1 participants with a BP less than 140/90 mm Hg and stable antihypertensive therapy, if used, including 145 assigned tirzepatide 5 mg, 152 assigned tirzepatide 10 mg, 148 assigned tirzepatide 15 mg, and 155 assigned placebo
Maiti A, MBBS, DiNardo CD, MD, MSCE, Rausch CR, PharmD, Pemmaraju N, MD, Garcia-Manero G, MD, Ohanian M, DO, Daver N, MD, Issa GC, MD, Borthakur G, MD, Ravandi F, MBBS, Alvarado Y, MD, Kadia TM, MD, Short NJ, MD, Jabbour EJ, MD, Montalban-Bravo G, MD, Jain N, MD, Kornblau SM, MD, Masarova L, MD, Wierda WG, Sasaki K, MD, PhD, Takahashi K, MD, PhD, Yilmaz M, MD, Burger JA, MD, PhD, Estrov ZE, MD, Verstovsek S, MD, PhD, Andreeff M , MD, PhD, Bose P, MD, Ferrajoli A, MD, Thompson PA, Montalbano K, Vaughan K, RN, Bivins CA, RN, Pierce SA, BSN, BA, Qiao W, PhD, Ning J, Welch J, PhD MD, Kantarjian H, MD, Konopleva M, MD, PhD